FDA
approval
· 2023-10-10
FDA Approved: LATANOPROST — Supplemental Application (Aurobindo Pharma Limited)
Summary
The FDA approved a supplemental application for latanoprost by Aurobindo Pharma Limited, approving a generic ophthalmic latanoprost product. It is indicated to …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LATANOPROST (LATANOPROST)